Memory Rehabilitation Strategies in Patients With Multiple Sclerosis

NCT ID: NCT05462678

Last Updated: 2022-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-01

Study Completion Date

2021-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical characteristics of MS are extremely variable from one patient to another. In about 60% of cases, motor disabilities are associated with cognitive deficits. The present study aims to compare three forms of cognitive / motor rehabilitation in three groups of patients with MS: rehabilitation of verbal memory with the Rehacom program; combined rehabilitation, associating a motor rehabilitation path with the Rehacom program; only motor rehabilitation course. Aims of the study will be: to verify whether the combined cognitive / motor rehabilitation can induce a significantly greater improvement in the memory performance of patients with MS compared to rehabilitation alone; check whether any improvement is objectively verifiable by patients and the impact it may have on patients' quality of life; monitor these effects after 6 months.

For these purposes, three homogeneous groups of 20 patients each will be enrolled, diagnosed with MS according to Mc Donald's criteria revisited by Polman (2011). The study will be divided into an initial clinical, cognitive, emotional, quality of life and functional self-perception (T0) assessment. Subsequently, the patients assigned to the three conditions will be provided with the pre-established rehabilitation treatments for a total duration of 12 weeks; at the end, each patient will undergo an overall re-evaluation (T1). Finally, a further overall reassessment will be carried out after 6 months, aimed at follow-up monitoring (T2).

Statistical analyzes will be of two types:

Within Group (aimed at assessing any improvement in the cognitive performance of each group of patients by comparing the assessments at T0 with those at T1 and T2); Between Group (aimed at comparing the results obtained by each group with those of the other 2 groups at T0, T1, and T2).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motor Rehabilitation

the third group carried out a traditional MR training.

Group Type EXPERIMENTAL

Motor Rehabilitation

Intervention Type BEHAVIORAL

Each patient performed two weekly sessions45 minutes each, for a total of 12 weeks.

Cognitive Rehabilitation

the first group carried out a training of CR by three memory modules of the Rehacom program (http://www.emsmedical.net).

Group Type EXPERIMENTAL

Cognitive Rehabilitation

Intervention Type BEHAVIORAL

Each patient performed two weekly sessions of 45 minutes each, for 12 weeks

Combined Training

the second group followed a mixed training program with the use of the version of the verbal memory module of the Rehacom program combined with the MR training.

Group Type EXPERIMENTAL

Combined Rehabilitation

Intervention Type BEHAVIORAL

Each patient performed one session per week (45 minutes) of CR and one session per week of traditional MR training for 12 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive Rehabilitation

Each patient performed two weekly sessions of 45 minutes each, for 12 weeks

Intervention Type BEHAVIORAL

Combined Rehabilitation

Each patient performed one session per week (45 minutes) of CR and one session per week of traditional MR training for 12 weeks.

Intervention Type BEHAVIORAL

Motor Rehabilitation

Each patient performed two weekly sessions45 minutes each, for a total of 12 weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of MS defined according to McDonald's diagnostic criteria revised in 2011.
* RRMS or SPMS phenotype.
* Language Italian mother tongue.
* EDSS score \<6.0

Exclusion Criteria

* Neurological or psychiatric pathologies other than MS that can interfere with cognitive functioning
* Clinical relapses in the three months prior to enrollment
* Severe mental illness
* Psychiatric disorders severe enough to interfere with cognitive functioning
* Medications Steroid therapy in the 3 months prior to enrollment
* Motor limitations Upper limb dysfunction (paralysis or tremor) that does not allow to hold the PC mouse
* Sensory limitations Visual acuity impaired enough to not allow reading of the instructions to the various tests
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

I.R.C.C.S. Fondazione Santa Lucia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ugo Nocentini, MD

Role: STUDY_DIRECTOR

I.R.C.C.S. "Santa Lucia" Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Santa Lucia Foundation I.R.C.C.S.

Roma, Rm, Italy

Site Status

I.R.C.C.S. "Santa Lucia" Foundation

Rome, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, Nocentini U. Motor, cognitive, and combined rehabilitation approaches on MS patients' cognitive impairment. Neurol Sci. 2023 Mar;44(3):1109-1118. doi: 10.1007/s10072-022-06552-4. Epub 2022 Dec 21.

Reference Type DERIVED
PMID: 36542204 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CE/PROG.698

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stylistic Memory Enhancement
NCT03206034 COMPLETED NA